Colonial River Wealth Management »

Regeneron Pharmaceuticals shares owned by Colonial River Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Colonial River Wealth Management from 13F filings

Historical chart of Colonial River Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Colonial River Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Colonial River Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $272k 484 562.27
2025-06-30 $251k 448 559.76
2023-03-31 $270k 329 821.67
2022-12-31 $246k 341 721.49
2022-09-30 $225k 326 690.18

More positions owned by Colonial River Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Applovin Corp Com Cl A (APP)
Palantir Technologies Cl A (PLTR)
Invesco Actively Managed Exc Total Return (GTO)
Invesco Exch Traded Fd Tr Ii 500 Qvm Multi (QVML)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)

View all positions for Colonial River Wealth Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals